Trial in progress: Feasibility of CSF and plasma ctDNA in BRAF-altered glioma during treatment with plixorafenib.

Authors: Karisa C. Schreck, Grace Tobin, Peng Huang, Michaella Iacoboni, Joy D. Fisher, Chetan Bettegowda

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2098

Source: Full article

---

Abstract

TPS2098